Trial intelligence / Profile preview

Dopaminergic modulation of cognition and psychomotor function in healthy volunteers

NL-OMON38372Recruiting

Sponsor
Maastricht University
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of methylphenidate, levodopa + carbidopa and Placebo-COD Research Private Ltd (3 arms), sponsored by Maastricht University. Primary endpoints: Contingent Negative Variation amplitude, Response time on response preparation tasks and 7 more. Started Jan 2011; status: recruiting.

02

Drugs

methylphenidatelevodopa + carbidopaPlacebo-COD Research Private Ltd

Beyond the preview

Go deeper on NL-OMON38372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call